We are live on ! Find out more
IART icon

Integra LifeSciences

259 hedge funds and large institutions have $3.96B invested in Integra LifeSciences in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

31% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 36

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

23% more capital invested

Capital invested by funds: $3.23B → $3.96B (+$731M)

4% more funds holding

Funds holding: 248259 (+11)

0.56% less ownership

Funds ownership: 83.99%83.43% (-0.56%)

58% less call options, than puts

Call options by funds: $7.84M | Put options by funds: $18.5M

Holders
259
Holders Change
+11
Holders Change %
+4.44%
% of All Funds
5.61%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
47
Increased
100
Reduced
80
Closed
36
Calls
$7.84M
Puts
$18.5M
Net Calls
-$10.6M
Net Calls Change
-$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
HSBC Holdings
176
HSBC Holdings
United Kingdom
$439K +$401K +7,879 New
TAM
177
Tiverton Asset Management
Delaware
$437K +$399K +7,842 New
DTL
178
Dynamic Technology Lab
Singapore
$434K -$1.16M -22,682 -74%
OC
179
Oppenheimer & Co
New York
$430K -$119K -2,340 -23%
SG Americas Securities
180
SG Americas Securities
New York
$414K +$98K +1,925 +35%
FRM
181
Fox Run Management
Connecticut
$406K +$371K +7,286 New
Squarepoint
182
Squarepoint
New York
$402K -$2.95M -58,016 -89%
IAM
183
Integre Asset Management
New York
$400K +$5.81K +114 +2%
P
184
Pitcairn
Pennsylvania
$399K +$102K +2,009 +39%
O
185
OppenheimerFunds
New York
$362K -$20.3M -399,417 -98%
PPCM
186
Pillar Pacific Capital Management
California
$362K -$11.5K -225 -3%
US Bancorp
187
US Bancorp
Minnesota
$359K -$24.6K -483 -7%
TRCT
188
Tower Research Capital (TRC)
New York
$351K +$321K +6,300 New
EGM
189
Engineers Gate Manager
New York
$340K -$2.64M -51,751 -89%
AAMU
190
Amundi Asset Management US
Massachusetts
$329K +$300K +5,900 New
PIA
191
Piedmont Investment Advisors
North Carolina
$327K +$1.38K +27 +0.5%
Citigroup
192
Citigroup
New York
$310K +$109K +2,132 +62%
FCI
193
Financial Counselors Inc
Kansas
$307K +$281K +5,510 New
LPL Financial
194
LPL Financial
California
$304K -$6.11K -120 -2%
LIA
195
LS Investment Advisors
Michigan
$299K +$1.94K +38 +0.7%
VIM
196
Vista Investment Management
Pennsylvania
$287K
QC
197
Quadrature Capital
United Kingdom
$283K +$258K +5,068 New
CCA
198
Conestoga Capital Advisors
Pennsylvania
$279K
RCM
199
Riverhead Capital Management
Delaware
$269K
JMPWA
200
JP Morgan Private Wealth Advisors
California
$255K +$233K +4,581 New

IART Hedge Fund Activity: Q1 2019 in Review

259 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2019, worth a combined $3.96B — up 23% from $3.23B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new IART positions and 36 closed out — a net gain of 11 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $35.1M. The largest seller was Fidelity Investments, cutting an estimated $77.3M.

  • 259 institutional investors held Integra LifeSciences (IART) as of Q1 2019, up from 248 in Q4 2018.
  • Funds reported $3.96B of Integra LifeSciences stock for Q1 2019, up 23% quarter-over-quarter.
  • 47 funds opened new Integra LifeSciences positions in Q1 2019 and 36 closed out, a net change of +11 holders.
  • The largest Integra LifeSciences buyer in Q1 2019 was Janus Henderson Group, an estimated $35.1M added.
  • The largest Integra LifeSciences seller in Q1 2019 was Fidelity Investments, an estimated $77.3M sold.

Based on aggregated 13F filings for Q1 2019.